» Articles » PMID: 22659407

Long-lasting Efficacy of the Cognitive Enhancer Cytotoxic Necrotizing Factor 1

Overview
Specialties Neurology
Pharmacology
Date 2012 Jun 5
PMID 22659407
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rho GTPases are key regulators of the activity-dependent changes of neural circuits. Besides being involved in nervous system development and repair, this neural structural plasticity is believed to constitute the cellular basis of learning and memory. Here we report that concurrent modulation of cerebral Rho GTPases, including Rac, Rho and Cdc42 subfamilies, by Cytotoxic Necrotizing Factor 1 (CNF1, 10 fmol/kg intracerebroventricularly) improves object recognition in both C57BL/6J and CD1 mice. The improvement is long lasting, as it is still observed 90 days post treatment. At this time, the treatment is associated with enhancement of neurotransmission and long-term potentiation. The effects depend on changes in Rho GTPase status, since the recombinant molecule CNF1 C866S, in which the enzymatic activity was abolished through substitution of serine to cysteine at position 866, is ineffective. The study confirms the role of Rho GTPases in learning and suggests that a single administration of CNF1 is effective for a long time after administration. In general, the long-lasting cognition enhancing effect of CNF1 might be beneficial for the treatment of CNS disorders. This article is part of a Special Issue entitled 'Cognitive Enhancers'.

Citing Articles

Hierarchical determinants in cytotoxic necrotizing factor (CNF) toxins driving Rho G-protein deamidation versus transglutamination.

Handy N, Xu Y, Moon D, Sowizral J, Moon E, Ho M mBio. 2024; 15(7):e0122124.

PMID: 38920360 PMC: 11253639. DOI: 10.1128/mbio.01221-24.


The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins.

Chaoprasid P, Dersch P Toxins (Basel). 2021; 13(12).

PMID: 34941738 PMC: 8709095. DOI: 10.3390/toxins13120901.


Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities.

Zamboni V, Jones R, Umbach A, Ammoni A, Passafaro M, Hirsch E Int J Mol Sci. 2018; 19(6).

PMID: 29925821 PMC: 6032284. DOI: 10.3390/ijms19061821.


Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Lefort R Neurotherapeutics. 2015; 12(1):19-28.

PMID: 25588580 PMC: 4322073. DOI: 10.1007/s13311-014-0328-4.


Differential role of Rac in the basolateral amygdala and cornu ammonis 1 in the reconsolidation of auditory and contextual Pavlovian fear memory in rats.

Wu P, Ding Z, Meng S, Shen H, Sun S, Luo Y Psychopharmacology (Berl). 2014; 231(15):2909-19.

PMID: 24553575 DOI: 10.1007/s00213-014-3462-0.